It is over 40 years since the original demonstration that thyroxine (T4), the principal secretory product of the thyroid, is deiodinated, to 3,5,3'-tri-iodothyronine (T3) in peripheral mammalian tissues. Subsequently it was shown that the antithyroid drug propylthiouracil (PTU) also blocked the metabolic effects of administered T4 in proportion to its inhibition of T4 to T3 conversion, indicating that deiodination was critical for T4 activation [l]. Subsequently, the type 1 deiodinase (Dl) was identified in mammalian liver, kidney and thyroid and was shown to be sensitive to inhibition by PTU, thus explaining the earlier results [2-41. This enzyme catalyses both outerand inner-ring deiodination of T4, but the preferred substrates are 3,3',5'-tri-iodothyronine ('reverse' T3; rT3) for outer-ring deiodination and the sulphate ester of T3 for inner-ring deiodination. Subsequently, a second, PTU-insensitive enzyme catalysing only T4 to T3 conversion was identified (type 2 deiodinase, D2), which had a K,,, for T4 one-thousandth that of D1 [5, 6] . The T 3 produced by this enzyme was critically important as a source of T3 receptor (TR)-bound T3 in the pituitary and the brain [7] . Subsequently, a third deiodinase (D3) was identified that inactivated T3 or T4 by the removal of an iodine from the inner ring, producing either rT3 or 3,3'-di-iodothyronine [8] . This enzyme was found principally in placenta, but also in the central nervous system. Both D1 and D3 activities are increased by thyroid hormone, whereas D2 activity is negatively regulated at a post-translational level. These results pointed to a family of enzymes whose activities are carefully regulated to maintain T3 homoeostasis both extracellularly and intracellularly.
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Despite the 60-fold higher levels of total T4 than T3 in plasma, the T4-to-T3 ratio of the free (metabolically available) hormones is about 3: 1. Because the binding affinity of TR for T3 is Abbreviations used: DEPC, diethylpyrocarbonate; Dn, type n deiodinase; PTU, propylthiouracil; rT3, 3,3',5',-tri-iodothyronine; SECIS, selenocysteine insertion sequence; T3, 3,3',5-tri-iodothyronine; T4, thyroxine; TR, T, receptor.
10-15-fold higher than for T4, T3 is the principal receptor-bound, active thyroid hormone. Physiological studies have shown that essentially all of the metabolic effects of T4 are derived from that fraction of the prohormone, about 35-40% in humans, that is monodeiodinated to T3. Thus the conversion of T4 to T 3 is the first step in thyroid hormone action. In turn, the level of T3 in the circulation and its half-life are determined by inner-ring deiodination catalysed by D3 and, to a smaller extent, D1.
The fact that all three of these enzymes are integral membrane proteins frustrated attempts to purify them to obtain a protein sequence. The approach that eventually proved to be successful in obtaining a cDNA was expression cloning with Xenopus oocytes. This allowed the identification of a 2.1 kb cDNA from rat liver encoding D1 [9] . An unexpected bonus of the expression cloning approach related to the fact that the active centre of this enzyme contains the rare amino acid selenocysteine, encoded by UGA. For virtually all eukaryotic mFWA species, UGA is a translation termination codon. There was considerable confusion regarding the protein sequence of this enzyme until it was finally recognized that the UGA in the centre of the open reading frame was not a stop codon [9] . Subsequent cloning of D3 and D2 have followed, although not without considerable effort and ingenuity [ 10-151. Especially useful was the knowledge of basic amphibian thyroid physiology derived from a number of earlier studies [16] . In fact, the first D3 and D2 cDNA species to be identified were from amphibian species.
Common features of the iodothyronine deiodinases
There are a number of important similarities between the selenodeiodinases as well as distinct differences ( Figure 1 and Table 1 ). First, as would be expected from the fact that these are integral membrane proteins, all three contain a hydrophobic sequence located in the N-terminal region of all three proteins. Topological studies of D1 have shown that this is a single membrane spanning domain [17] . In D1, there is a short . T h e area of highest similarity between the three enzymes surrounds the active centre, which contains selenocysteine (denoted by an asterisk in Figure 1 ). Presumably these residues are critical to the maintenance of the iodine transfer process and Se-regeneration. Early studies showed that a histidinespecific reagent [diethylpyrocarbonate (DEPC)] caused the inactivation of D1, suggesting the presence of essential histidine residues [20] . There are only two conserved histidine residues in the four species of D1 so far cloned (at positions 158 and 174) and both were found to be essential by mutagenesis studies (Figure 1 ). Changing His-1 58 to glutamine, asparagine or phenylalanine resulted in a complete loss of deiodinating activity, indicating a probable essential structural role [21] . Mutation of His-174 in D1 to glutamine or asparagine caused a 20-100-fold increase in the K,, for rT3 and markedly reduced the sensitivity of D1 to DEPC. His residues corresponding to both of these are conserved in all three enzymes. His-174 may play a role in protecting the Se atom from oxidation. In addition to these common features, the C-terminal portions of the proteins resemble one another much more closely than do their N-termini (Figure 1 ).
The canine D1 has a 10-fold higher K,, for the preferred substrate r T j than do the rat, human or mouse D1 enzymes. Comparative studies localized the critically important difference to the phenylalanine residue at position 65 [22] (Figure 1 ). In the canine D1, Phe-65 is replaced with leucine and this substitution in the human D1 causes an identical 10-fold increase in the K,,, for rT3 [22] . Interestingly, whereas this residue is critically important for the 5' deiodination of rT3, there is no difference between the human and canine D1 enzymes with respect to 5' deiodination of T, or for inner-ring deiodination of T3 sulphate. This suggests that Phe-65 is especially important for the interaction of D1 with iodothyronine substrates containing only a single iodine substitution on the inner ring, such as rT3 or 3,3'-di-iodothyronine. There is no conservation of this residue in either D3 or D2.
A critical element shared by the three selenodeiodinases is the presence of a mechanism for suppressing the 'stop' codon function of the UGA codon present in the centre of the open reading frame. In the initial studies of D1, deletion of the 3' untranslated region of the niRNA eliminated the expression of the wild-type D1 but not a cysteine mutant enzyme. This was eventually explained by the presence of a stem loop structure in the 3' untranslated region of the D1 mRNA approx. 600 nucleotides 3' of the stop codon [23, 24] . When other eukaryotic selenoprotein mRNA species were examined, similar structures were identified. This led to the concept that this stem loop sequence was required for read-out of the UGA codon as selenocysteine as opposed to a stop. This activity is encompassed in the term 'selenocysteine insertion sequence' (SECIS) element. A similar structure had been identified in the coding sequence immediately 3' of the UGA of prokaryotic selenoproteins [25] . Presumably the mechanism of action of the SECIS element is the same in prokaryotes and eukaryotes but the position of the SECIS element in the 3' untranslated region allows greater flexibility in the coding region. So far a SECIS element has been identified in the cDNA species of all four species of D1, in two species of D3 and one (Rana catesbeiana) of D2 as well as in the other known eukaryotic selenoproteins. However, the SECIS element of the mammalian D2 mRNA species has not as yet been located. This is probably due to the fact that the cDNA sequences for these proteins are incomplete with only approx. 2.5 kb of an estimated 7.5 kb cDNA reported so far.
Specific characteristics of each deiodinase
D1 catalyses the removal of an iodine from either the inner or the outer ring of T4 with approximately equal efficiency, but rT3 and T3 sulphate are the preferred substrates (Table 1 ). T h e K,, of D2 for T q is one-thousandth that of D1. D1 catalyses inner-ring deiodination of the sulphated derivative of T3, which it deiodinates rapidly, but T3 sulphate is not a substrate for D3 [26, 27] . In fact, in animals given PTU, there is a marked increase in plasma T3 sulphate. T3 is also elevated in human cord serum secondary to the markedly suppressed values of D1 in the fetal state [28, 29] . T h e proposed enzymic scheme for T4 deiodination by D1 is shown in Figure 2 [20] .
The reaction follows Ping Pong kinetics with the iodothyronine and an as yet unidentified thiolcontaining cofactor as the co-substrates. When a cysteine residue is substituted for selenocysteine in D1, there is a decrease to one-hundredth in Volume 25 is the higher nucleophilicity of selenium than that of sulphur. T h e PK, of selenocysteine is about two orders of magnitude lower than that of cysteine. Because Se is negatively charged at physiological pH, the enzyme is quite sensitive to inhibition by positively charged heavy metals such as gold (Figure 2 ), although this sensitivity is also partly based on the enzyme structure. Deiodination by D1 is inhibited by PTU because this reagent competes with the thiol cofactor in the regeneration of the enzyme. D2 and D3 are only minimally sensitive to PTU, which may be a function of a lower turnover number [22] . D1 is a thyroid hormone-responsive enzyme; two thyroid hormone response elements have been identified in the 5' flanking region of this gene [9, 31] . One of these is a typical direct repeat hexamer with a 4 bp spacing but the second element seems to be a complex of two idealized octameric half-sites located on the antisense strand about 100 nucleotides 5' of the transcription start site. These monomeric halfsites bind T R monomers, not retinoid X receptor-TR heterodimers.
D2 is the most recently cloned of the three cDNA species and we know least about its structural-functional features [ 11, 13, 15] . One of the most surprising results about D2 are the differences in tissue-specific expression between rats and humans. D2 is expressed in rat and human central nervous system, pituitary, brown fat and placenta, and also in human, but not in rat, thyroid, skeletal and cardiac muscle [ 13, 15, 32] . The presence of D2 in human skeletal muscle raises questions about our current concepts of peripheral thyroid hormone activation in humans, which have been based largely on experiments in rats. Thus, whereas we have previously thought that D2 provides primarily intracellular T3, we now must consider the possibility that in humans it can provide plasma T 3 as well. Production of plasma T3 by D2 has previously been documented in the chronically cold-exposed rat, presumably from brown fat [33] . T h e presence of high levels of D2 in human thyroid is especially interesting and unexpected [32] mRNA is markedly higher in Graves' thyroid than in normal thyroid tissues. Virtually all the T3 produced by microsomes from Graves' thyroids is generated by D2 rather than by the D1 that is also present in this tissue [32] .
T h e expression of D2 mRNA is increased in the hypothyroid rat [ 131. Together with earlier studies, this indicates both pre-and post-translational regulation of this enzyme by T4. The mechanism for substrate-induced inactivation of D2 is poorly understood. As mentioned, deiodination catalysed by D2 is relatively resistant to PTU and to gold, even though this enzyme contains selenocysteine as demonstrated by selenium labelling. In fact, both the rat and human D2 contain a second UGA codon eight residues from the C-terminus (Figure 1 ) [13, 15] . This residue can be recognized as selenocysteine or as a stop codon during transient expression [ 151.
D3 is the major enzyme inactivating T3 and T4. The human D3 mRNA contains a SECIS element that is 2-3 times more potent than that in the D1 enzyme and D3 is also resistant to PTU and gold [14] . As might be expected, D3 mRNA is induced in the central nervous system by T3 and it is decreased in hypothyroidism (H. Tu, T. Bartha, G. Legradi, D. Salvatore, P.R.
Larsen and R.M. Lechan, unpublished work). These changes mirror those for D2, resulting in a homoeostatic intracellular mechanism for maintaining T3 concentrations at a constant level. D3 is most highly expressed in placenta, where it seems to block the access of material T3 and T, to the fetus for reasons that are still not clear [34] . Although some T, escapes D3 inactivation, this is an important component of the fetal defence against maternal thyroid hormone [29] .
At present we have only begun to explore the processes regulating thyroid hormone activation and inactivation. T h e next few years should bring a major increase of our knowledge consequent to' the application of modern molecular biological techniqus to the study of the physiological role of these interesting and unusual proteins.
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